This paper describes an innovation framework that fosters public-private partnership as a means to overcoming the barriers of developing medicines to combat neglected diseases. We define neglected diseases as those therapeutic areas for which a great unmet need exists but for which market demand...

BACKGROUND Consistent with good corporate citizenship and the role of multinational pharmaceutical corporations in producing social goods, there is a need to clarify the concept of global burden of disease (GBD) and create performance metrics that measure a firm’s contribution to ‘saving...

What is the relationship between technological innovation, entrepreneurship and development? Is it better for developing countries to coping and adapt existing technologies from richer countries rather than undertake or promote intensive research and development (R&D) of their own? We tackle...